Ask someone to name the most important physicist of the 20 th century, and they will almost certainly say Albert Einstein. Ask the same question about the field of mathematics, however, and you will ...

Abstract: To address the discrepancy between geodetic coordinates provided by navigation equipment on autonomous underwater vehicles (AUVs) and Cartesian coordinates employed for calculating Euclidean ...

Cartesian Therapeutics, Inc. has announced the enrollment of the first participant in its Phase 3 AURORA trial for Descartes-08, its lead cell therapy candidate aimed at treating myasthenia gravis (MG ...

Cartesian Therapeutics updates on Descartes-08 trials in myasthenia gravis and lupus, with financial results highlighting $182.1 million in cash. Cartesian Therapeutics, Inc. has announced the ...

NEW YORK--(BUSINESS WIRE)--Cartesian Growth Corporation III (the “Company”) announced today the pricing of its initial public offering of 24,000,000 units, upsized from 20,000,000 units, at a price of ...

Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol Assessment ...

All the tech we rely on, from cars to smartphones, was engineered using physics. You don’t need to know the science to use these things. But a well-rounded human should understand at least some of the ...

Moving an object from one location to another—picking and placing—is an ideal application for industrial robots due to the robots’ repeatability, throughput and favorable return on investment. It is ...

Physicists including Robert H. Dickle and Fred Hoyle have argued that we are living in a universe that is perfectly fine-tuned for life. Following the anthropic principle, they claimed that the only ...

The education secretary has said GCSE students should continue to be given formula and equation sheets to help in their exams. This year had been the final year students were expecting to receive that ...

Cartesian Therapeutics has claimed a phase 2b win for its BCMA-directed CAR-T therapy in generalized myasthenia gravis (gMG). But the biotech’s victory came on a primary endpoint it changed in May and ...